Retraction-Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

16 citing papers in PubMed.

1. Cellular senescence and cell therapy in cardiovascular diseases.Stem cell research & therapy · 2025
   Review
2. Injectable Stem Cell-Based Therapies for Myocardial Regeneration: A Review of the Literature.Journal of functional biomaterials · 2025
   Review
3. Cardiac progenitor cell therapy: mechanisms of action.Cell & bioscience · 2024
   Review
4. Who Should Be Accountable for Scientific Accountability?JACC. Basic to translational science · 2023
   Article
5. Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments.Biomedicines · 2023
   Review
6. The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology.Tissue engineering and regenerative medicine · 2022
   Review
7. Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside.EClinicalMedicine · 2022
   Review
8. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.Cardiovascular research · 2022
   Review
9. Cardiac regeneration following myocardial infarction: the need for regeneration and a review of cardiac stromal cell populations used for transplantation.Biochemical Society transactions · 2022
   Review
10. [Cardiac cell therapy-Lost in translation?]Zeitschrift fur Herz-, Thorax- und Gefasschirurgie · 2022
    Review
11. Fake It Till You Make It: What Every Translational Investigator Can Learn From the Rise and Fall of Theranos.JACC. Basic to translational science · 2022
    Article
12. Stem Cells in Cardiovascular Diseases: 30,000-Foot View.Cells · 2021
    Review
13. After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease.Canadian journal of physiology and pharmacology · 2021
    Review
14. Differentiation of Human Cardiac Atrial Appendage Stem Cells into Adult Cardiomyocytes: A Role for the Wnt Pathway?International journal of molecular sciences · 2020
    Article
15. Cardiac Progenitor Cells from Stem Cells: Learning from Genetics and Biomaterials.Cells · 2019
    Review
16. Function Follows Form　- A Review of Cardiac Cell Therapy.Circulation journal : official journal of the Japanese Circulation Society · 2019
    Review

Corrections and comments

• Retraction of
  Retracted: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.